Cargando…

Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis

Psoriasis is a chronic inflammatory skin pathology of autoimmune origin and unknown etiology. There are various therapies for treating it, including a wide range of biopharmaceuticals indicated in moderate-to-severe psoriasis. Depending on their therapeutic target, they are classified as tumor necro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Membrive Jiménez, Cristina, Pérez Ramírez, Cristina, Sánchez Martín, Almudena, Vieira Maroun, Sayleth, Arias Santiago, Salvador Antonio, Ramírez Tortosa, María del Carmen, Jiménez Morales, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069496/ https://www.ncbi.nlm.nih.gov/pubmed/33921427 http://dx.doi.org/10.3390/jpm11040293

Ejemplares similares

Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021)

ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023)

Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023)

Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review
por: Cura, Yasmin, et al.
Publicado: (2023)

Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 Genes as Biomarkers of Survival in Non-Small Cell Lung Cancer: A Systematic Review
por: Pineda-Lancheros, Laura Elena, et al.
Publicado: (2023)

Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway and Their Relationship with High Blood Pressure Risk
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
por: Pineda Lancheros, Laura Elena, et al.
Publicado: (2021)

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis
por: Zarzuelo Romero, María José, et al.
Publicado: (2021)

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis
por: Marquez Pete, Noelia, et al.
Publicado: (2020)

Vitamin D-Related Single Nucleotide Polymorphisms as Risk Biomarker of Cardiovascular Disease
por: González Rojo, Paula, et al.
Publicado: (2022)

Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients
por: Zarzuelo-Romero, María José, et al.
Publicado: (2021)

Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
por: Cura, Yasmin, et al.
Publicado: (2023)

Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Ramírez-Tortosa, César L., et al.
Publicado: (2022)

Effect of Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway on Susceptibility to Non-Small-Cell Lung Cancer
por: Pineda Lancheros, Laura Elena, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway as Survival Biomarkers in Colorectal Cancer
por: Pérez-Durán, Carmen, et al.
Publicado: (2023)

Study of Skin Barrier Function in Psoriasis: The Impact of Emollients
por: Maroto-Morales, Daniel, et al.
Publicado: (2021)

PILOT STUDY OF SEXUAL DYSFUNCTION IN PATIENTS WITH PSORIASIS: INFLUENCE OF BIOLOGIC THERAPY
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Erythema Increase Predicts Psoriasis Improvement after Phototherapy
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2021)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Biological therapies in moderate and severe psoriasis: perspectives and certainties
por: Constantin, MM, et al.
Publicado: (2014)

THE MANAGEMENT OF MODERATE TO SEVERE PSORIASIS: A BIOLOGIC REVOLUTION
por: Skillen, LA, et al.
Publicado: (2018)

Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance
por: Gonzalez-Cantero, Alvaro, et al.
Publicado: (2019)

Use of Biological Treatments in Elderly Patients with Skin Psoriasis in the Real World
por: Osuna, Cristina Galache, et al.
Publicado: (2021)

Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study
por: SÁNCHEZ-DÍAZ, Manuel, et al.
Publicado: (2023)

Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review
por: Ferrer-Alcala, Maria-Angeles, et al.
Publicado: (2021)

Treatment Approaches to Moderate to Severe Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2017)

Burnout in Palliative Care Nurses, Prevalence and Risk Factors: A Systematic Review with Meta-Analysis
por: Gómez-Urquiza, Jose Luis, et al.
Publicado: (2020)

Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis
por: Prieto-Pérez, Rocío, et al.
Publicado: (2015)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
por: Molina-Leyva, Alejandro, et al.
Publicado: (2015)

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis
por: Márquez Pete, Noelia, et al.
Publicado: (2021)

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
por: Coto-Segura, Pablo, et al.
Publicado: (2023)

Association between Single Nucleotide Polymorphisms Related to Vitamin D Metabolism and the Risk of Developing Asthma
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Infections in Patients Receiving Subcutaneous Biological Treatments for Moderate to Severe Psoriasis
por: Messori, Andrea, et al.
Publicado: (2015)

Moderate to severe psoriasis treatment challenges through the era of biological drugs
por: Vide, Júlia, et al.
Publicado: (2017)

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
por: Barker, Jonathan, et al.
Publicado: (2021)

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
por: Golhen, Klervi, et al.
Publicado: (2022)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer
por: Ramirez-Tortosa, Cesar, et al.
Publicado: (2019)

Factors related to the appearance and development of burnout in nursing students: a systematic review and meta-analysis
por: Velando-Soriano, Almudena, et al.
Publicado: (2023)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_i8hjjk12e2t6ev6jgqa27essco